http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
임치영(Chi Young Lim),이잔디(Jan Dee Lee),남기현(Kee Hyun Nam),장항석(Hang Seok Jang),김혜령(Hae ryoung Kim),박정수(Cheong Soo Park) 대한두경부종양학회 2005 대한두경부 종양학회지 Vol.21 No.1
Myasthenia gravis with thymoma is associated with an increased risk of second malignancy, but concurrence of myasthenia gravis and thyroid carcinoma is rarely seen. In the treatment, it is emphasized to operate in two stage to avoid myasthenic crisis after surgery. In general, a thyroid cancer surgery is performed after controlling yasthenia gravis by means of thymectomy or medical treatment with steroids and anticholine esterase. We experienced two cases of thyroid carcinoma coexisting with myasthenia gravis, which is thought to be true first report in Korea.
그레이브스씨병(Graves` disease) 환자에서 수질암(medullary thyroid carcinoma)이 동반된
공지현 ( Jee Hyun Kong ),김철식 ( Chul Sik Kim ),조민호 ( Min Ho Jo ),안철우 ( Chul Woo Ahn ),김경래 ( Kyung Rae Kim ),장항석 ( Hang Seok Jang ),홍순원 ( Soon Won Hong ) 대한내과학회 2005 대한내과학회지 Vol.69 No.-
It is believed that Graves` disease is associated with an increased prevalence of thyroid carcinoma, but the reported incidence is variable, ranging between 0% and 9.8% generally of differentiated thyroid carcinoma type. The majority of thyroid carcinomas in patients with Graves` disease are papillary, followed in frequency by follicular carcinoma. Medullary thyroid carcinoma in combination with Graves` disease appears to be very rare. To our knowledge, only 11 cases have been described in which medullary thyroid carcinoma associated Graves` disease and all of them, at foreign countries. So we experienced medullary thyroid carcinoma associated Graves` disease, we report this case with review of literature. (Korean J Med 69:S851-S855, 2005)
일차성 및 이차성 부갑상선기능항진증 환자에서 Doucle-Phase Tc-99m Sestamibi 스캔에 의한 병변의 국소화에 관한 비교
이종두,박정수,유영훈,전태주,장항석 대한핵의학회 1999 핵의학 분자영상 Vol.33 No.4
Purpose: The purpose of this study was to evaluate and compare the scintigraphic findings and diagnostic accuracy of double-phase Tc-99m sestamibi scan in primary and secondary hyperparathyroidism (HPT). Materials and Methods: We retrospectively reviewed 16 cases of primary (18 lesions) and 11 cases of secondary HPT (44 lesions) who underwent Tc-99m-sestamibi scan before the surgical intervention. Scan was performed using LEM camera (Siemens, Germany) after the injection of 740MBq of Tc-99m sestamibi. Routine image consisted of baseline and 3-hour delayed images and each image was obtained using both parallel and pine hole collimator. The study population was 27 patients (male/female=5/22, age: 49.1±10.8). Results: Eighteen lesions of primary HPT consisted of 13 adenomas and 5 hyperplasias, while all lesions of secondary HPT were hyperplasias. Among the case of primary HPT, we could detect all the lesions of 13 adenomas but only 2 lesions of 5 hyperplasias (40%) could be detected by double phase scintigraphy Three cases of primary lesion showed decreased uptake in delayed images compared with baseline. The sensitivity, specificity, positive predictive value and accuracy of primary and secondary HPT were 58.8% (10/17), 83.3% (10/12), 83.3% (10/12), 75.9% (22/29), and 37.5% (15/40), 50% (2/4), 88.2% (15/17), 38.6% (17/44), respectively. Overall sensitivity, specificity, positive predictive value and accuracy were 43.9% (25/57), 75% (12/16), 86.2% (25/29), and 53.4% (39/73). There were no statistical difference between the weight of primary and secondary HPT lesion (p$gt;0.05). Conclusion: Tc-99m sestamibi scan is fairly good modality to detect parathyroid lesion in patient with primary HPT before the surgical intervention. However, since some of cases may reveal decreased uptake in delayed image, a careful attention to the findings of baseline images may be helpful. Still the low accuracy of sestamibi scan in diagnosis of secondary HPT prohibits routine use of it for this disease.